信佳國際(00912.HK)旗下信佳電子任命John Bastianelli為首席產品及創新總監
信佳國際(00912.HK)宣布,正式任命John Bastianelli為旗下「信佳電子有限公司」首席產品及創新總監(Chief Product & Innovation Officer, CPIO);此項人事任命將進一步鞏固集團在全方位電子解決方案領域的領先地位。
集團行政總裁吳民卓表示,John Bastianelli在產品創新和商業化方面的卓越成就,將為信佳帶來全新的發展動能。相信憑藉其豐富的行業經驗和創新視野,將進一步提升集團在ODM和JDM業務領域的競爭優勢,共同為客戶創造更大價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.